Another notable buy includes CRISPR Therapeutics AG (NASDAQ: CRSP ), with ARKK ETF purchasing 31,983 shares, reflecting a continued investment in the gene-editing company with a total dollar value of ...

UiPath appears to be struggling with making the Agentic AI potential show up on the balance sheet. Click here to read an analysis of PATH stock now.

We recently published a list of the 13 Best Artificial Intelligence Stocks Under $50 to Buy Now. In this article, we are ...

C3.ai, Inc. and UiPath Inc. are both high-profile players in the booming AI automation sector. C3.ai specializes in ...

In this features, UiPath Chief People Officer Agnes Garaba, reveals how the company’s HR team is reshaping the future of work by emotional intelligence with agentic AI.

UiPath's FY26E and FY27E revenue projections are modestly above Street due to underappreciated core platform resilience. Read ...

The UiPath Platform for agentic automation provides increased productivity, improved customer experiences, enhanced compliance, and accelerated digital transformation UiPath (NYSE: PATH), a global ...

UiPath announced that it has been named a Leader in the IDC MarketScape: Worldwide Business Automation Platforms 2025 Vendor ...

Detailed price information for Uipath Inc Cl A (PATH-N) from The Globe and Mail including charting and trades.

US-headquartered enterprise automation firm UiPath has expanded its India footprint to two additional cities — Pune and ...

Belgium Campus iTversity has partnered with UiPath to advance its training capabilities in software automation and AI. By becoming an UiPath Academic Alliance member, the education institution will ...

BPX Helps Organizations Optimize Digital Workflows Using Process Mining Technology With the increasing pace of digital transformation in bu ...